OBJECTIVE The Woven EndoBridge (WEB) received FDA approval for endovascular treatment of wide-necked bifurcation aneurysms. We evaluated the feasibility, safety and efficacy of the WEB for the treatment of narrow-necked… Click to show full abstract
OBJECTIVE The Woven EndoBridge (WEB) received FDA approval for endovascular treatment of wide-necked bifurcation aneurysms. We evaluated the feasibility, safety and efficacy of the WEB for the treatment of narrow-necked aneurysms. METHODS This multi-center study included 17 narrow-necked aneurysms, defined by a neck width < 4 mm and a dome-to-neck ratio > 2. Aneurysm characteristics, treatment strategies, technical success, complications and angiographic outcomes were retrospectively assessed. RESULTS The aneurysms were located at the internal carotid artery in 7 cases, the anterior communicating artery in 4, the middle cerebral artery in 4, and the basilar artery in 2. The median aneurysm size was 7.4 mm with a median neck width of 2.3 mm. The technical success rate was 100%. There were no neurological complications. Angiographic control revealed complete and adequate occlusion in 13/15 (86.7%) and 14/15 (93.3%) after 6 months, respectively, and in 6/7 (85.6%) and 7/7 (100%) after a median of 13 months, respectively. Two aneurysms were retreated with flow-diverters. CONCLUSIONS WEB embolization of narrow-necked aneurysms was technically feasible and safe and might be considered as alternative treatment option to conventional coiling in selected cases.
               
Click one of the above tabs to view related content.